Alcohol-induced cardiac diseases;Patologie cardiache alcool-correlate

Giornale Italiano di Cardiologia

Volumn 10, Issue 1, 2009, Pages 18-27

  Correale, Michele ^a   Laonigro, Irma ^b   Altomare, Emanuele ^b   Di Biase, Matteo ^a  

^a Univ degli Study di Foggy   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Alcoholic cardiomyopathy; Diastolic dysfunction; Systolic dysfunction

Indexed keywords

ANTICOAGULANT AGENT; ATRIAL NATRIURETIC FACTOR; CALCIUM CHANNEL; SUPEROXIDE DISMUTASE; THIAMINE;

ALCOHOL CONSUMPTION; ALCOHOLIC CARDIOMYOPATHY; ALCOHOLISM; APOPTOSIS; COLOR ULTRASOUND FLOWMETRY; CORONARY ARTERY ATHEROSCLEROSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIASTOLIC DYSFUNCTION; ELECTROCARDIOGRAM; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; INCIDENCE; MITRAL VALVE DISEASE; OXIDATIVE STRESS; REVIEW; SYSTOLIC DYSFUNCTION; UPREGULATION; ADULT; ANIMAL; COMPARATIVE STUDY; DIASTOLE; DISEASE MODEL; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; HEART ARREST; HEART ARRHYTHMIA; HEART DISEASE; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE FUNCTION; HEART STROKE VOLUME; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; SUDDEN DEATH; SYSTOLE;

ADULT; ALCOHOLISM; ANIMALS; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHY, ALCOHOLIC; DEATH, SUDDEN, CARDIAC; DIASTOLE; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; HEART ARREST; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; STROKE VOLUME; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT;

EID: 64049096410     PISSN: 18276806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (108)

1. Baumberg B. The global economic burden of alcohol: a review and some suggestions. Drug Alcohol Rev 2006; 25: 537-51. (Pubitemid 44837644)
2. Piano MR. Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology. Chest 2002; 121: 1638-50. Importante rassegna sull'incidenza, le caratteristiche cliniche e la fisiopatologia della cardiomiopatia alcolica. È sottolineata l'importanza dell'astensione dal bere per il recupero della funzione ventricolare.
3. Rubin E. Alcoholic myopathy in heart and skeletal muscle. N Engl J Med 1979; 301: 28-33.
4. Huss M. Chronische Alkoholskrankheit oder Alkoholismus chronicus, Ein Bietrag zur Kenntnis der Vergiftungs-Krankheiten. Prevedeno sa svedskoga, 1852
5. Bazzani O, Bertazzoni G, Salerno MT, et al. Documento unico del gruppo di lavoro trattamento e riabilitazione. In: Ceccanti M, Patussi V, eds. Atti della I Consensus Conference sull'Alcool. Firenze: Scientific Press, 1995: 161-82.
6. Pierri G. Classificazione in psichiatria. In: Pierri G, ed. Compendio di psichiatria. Diagnosi e terapia dei disturbi mentali e del comportamento. Milano: Casa Editrice Ambrosiana, 1993: 229-45.
7. Hudolin V. La diagnostica nell'alcolismo e nei problemi alcolcorrelati. In: Hudolin V, ed. Manuale di algologia. Trento: Edizione Centro Studi Erickson, 1991: 81.
8. Wood GB. A treatise on the practice of medicine. Philadelphia, PA: Lippincott, 1855.
9. Bollinger O. Uber die Hanfigkeit und ursachen der idiopatischen herzypertrophie. Munchen Dtsch Med Wochenschr, 1884.
10. Steel G. Alcoholic cardiomyopathy. Med Chron 1893; 18: 100.
11. Aalsmeer WC, Wenckenbach KF. Herz und kreislauf bei der beri-beri krankheit. Wien Arch Ann Med 1929; 16: 193.
12. Weiss S, Wilkins RW. The nature of the cardiovascular disturbances in vitamin deficiency states. Trans Assoc Am Phys 1936; 51: 341.
13. Blankenhorn MA. Diagnosis of beri-beri heart disease. Ann Intern Med 1945; 23: 398.
14. Hudolin V. Vincere l'alcolismo, Alessandria: Piemme, 1993: 34.
15. Lee WK, Regan TJ. Alcoholic cardiomyopathy: is it dose-dependent? Congest Heart Fail 2002; 8: 303-6.
16. Cooper HA, Exner DV, Domanski MJ. Light-to-moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2000; 35: 1753-9.
17. Djoussé L, Gaziano JM. Alcohol consumption and risk of heart failure in the Physicians' Health Study I. Circulation 2007; 115: 34-9. Analisi di un'ampia popolazione (oltre 21 000 pazienti) con un lungo follow-up (follow-up medio 18.4 anni) per valutare la relazione tra bere moderato e rischio di sviluppare insufficienza cardiaca. (Pubitemid 46058609)
18. Ceccanti M. Alcol e dintorni. Roma: Momento Medico, 1989.
19. Roberts WC, Siegel RJ, McManus BM. Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 1987; 60: 1340-55.
20. Rosengren A, Wilhelmsen L, Pennert K, Berglund G, Elmfeldt D. Alcoholic intemperance, coronary heart disease and mortality in middle-aged Swedish men. Acta Med Scand 1987; 222: 201-13.
21. Ettinger Po, Wu CF, De La Cruz CL Jr, Weisse AB, Ahmed SS, Regan TJ. Arrhythmias and the "Holiday Heart": alcohol-associated cardiac rhythm disorders. Am Heart J 1978; 95: 555-62.
22. Cohen EJ, Klatsky AL, Armstrong MA. Alcohol use and supraventricular arrhythmia. Am J Cardiol 1988; 62: 971-3.
23. Vikhert AM, Tsiplenkova VG, Cherpachenko NM. Alcoholic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol 1986; 8 (1 Suppl A): 3A-11A.
24. Patel R, McArdle JJ, Regan TJ. Increased ventricular vulnerability in a chronic ethanol model despite reduced electrophysiologic responses to catecholamines. Alcohol Clin Exp Res 1991; 15: 785-9.
25. Regan TJ, Pathan A, Weiss AB, Eaddy C, Torres R. The contribution of arterial pressure to the cardiac dysfunction of chronic alcoholism. Acta Med Scand Suppl 1985; 703: 273-80.
26. Ahmed SS, Levinson GE, Regan TJ. Depression of myocardial contractility with low doses of ethanol in normal man. Circulation 1973; 48: 378-85.
27. Child JS, Kovich RB, Levisman JA, Pearce ML. Cardiac effects of acute ethanol ingestion unmasked by autonomic blockade. Circulation 1979; 59: 120-5.
28. Conway N. Haemodynamic effects of ethyl alcohol in patients with coronary heart disease. Br Heart J 1968; 30: 638-44.
29. Gould L, Umali F, Gomprecht RF, Zahir M, Jaynal F. Cardiac effects of alcohol in alcoholics. Q J Stud Alcohol 1972; 33: 966-78.
30. Maguire R. Acute dilatation of the heart produced by alcoholism. Br Med J 1887; 1: 1215.
31. Burch GE, Giles TD. Alcoholic cardiomyopathy: concept of the disease and its treatment. Am J Med 1971; 50: 141-5.
32. Report of the World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Br Heart J 1980; 44: 672-3.
33. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996; 93: 841-2.
34. Fernández-Solá J, Estruch R, Grau JM, Pare JC, Rubin E, Urbano- Marquez A. The relation of alcoholic myopathy to cardiomyopathy. Ann Intern Med 1994; 120: 529-36.
35. Preedy VR, Atkinson LM, Richardson PJ, Peters TJ. Mechanisms of ethanol-induced cardiac damage. Br Heart J 1993; 69: 197-200.
36. Urbano-Marquez A, Estruch R, Fernández-Solá J, Nicolás JM, Paré JC, Rubin E. The greater risk of alcoholic cardiomyopathy and myopathy in women compared with men. JAMA 1995; 274: 149-54.
37. Fernández-Solá J, Estruch R, Urbano-Márquez A. Alcohol and heart muscle diseases. Addict Biol 1997; 2: 9-17.
38. Fernández-Solá J, Estruch R, Nicolás JM, et al. Comparison of alcoholic cardiomyopathy in women versus men. Am J Cardiol 1997; 80: 481-5.
39. Kimmelstiel CD, Konstam MA. Heart failure in women. Cardiology 1995; 86: 304-9.
40. De Maria R, Gavazzi A, Recalcati F, Baroldi G, De Vita C, Camerini F. Comparison of clinical findings in idiopathic dilated cardiomyopathy in women versus men. The Italian Multicenter Cardiomyopathy Study Group (SPIC). Am J Cardiol 1993; 72: 580-5.
41. Urbano-Márquez A, Estruch R, Navarro-Lopez F, Grau JM, Mont L, Rubin E. The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med 1989; 320: 409-15. (Pubitemid 19059272)
42. Constant J. The alcoholic cardiomyopathies - genuine and pseudo. Cardiology 1999; 91: 92-5.
43. Haunstetter A, Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res 1998; 82: 1111-29. (Pubitemid 28311120)
44. Cartwright MM, Smith SM. Increased cell death and reduced neural crest cell numbers in ethanol-exposed embryos: partial basis for the fetal alcohol syndrome phenotype. Alcohol Clin Exp Res 1995; 19: 378-86.
45. Chen DB, Wang L, Wang PH. Insulin-like growth factor I retards apoptotic signaling induced by ethanol in cardiomyocytes. Life Sci 2000; 67: 1683-93.
46. Bristow MR. Beat-adrenergic receptor blockade in chronic heart failure. Circulation 2000; 101: 558-69.
47. Fernández-Solá J, Fatjó F, Sacanella E, et al. Evidence of apoptosis in alcoholic cardiomyopathy. Hum Pathol 2006; 37: 1100-10. Studio sperimentale dimostrante che meccanismi proapoptotici sono attivati in pazienti dediti all'alcol senza ancora evidenza di danno miocardico.
48. 2+ flux dysfunctions are reversible. J Mol Cell Cardiol 1981; 13: 443-55.
49. Segel LD, Rendig SV, Choquet Y, Chacko K, Amsterdam EA, Mason DT. Effects of chronic graded ethanol consumption on the metabolism, ultrastructure, and mechanical function of the rat heart. Cardiovasc Res 1975; 9: 649-63.
50. Sarma JS, Ikeda S, Fischer R, Maruyama Y, Weishaar R, Bing RJ. Biochemical and contractile properties of heart muscle after prolonged alcohol administration. J Mol Cell Cardiol 1976; 8: 951-72.
51. Alexander CS. Electron microscopic observations in alcoholic heart disease. Br Heart J 1967; 29: 200-6.
52. Tsiplenkova VG, Vikhert AM, Cherpachenko NM. Ultrastructural and histochemical observations in human and experimental alcoholic cardiomyopathy. J Am Coll Cardiol 1986; 8 (1 Suppl A): 22A-32A.
53. Bing RJ, Tillmanns H, Fauvel JM, Seeler K, Mao JC. Effect of prolonged alcohol administration on calcium transport in heart muscle of the dog. Circ Res 1974; 35: 33-8.
54. Pachinger OM, Tillmanns H, Mao JC, Fauvel JM, Bing RJ. The effect of prolonged administration of ethanol on cardiac metabolism and performance in the dog. J Clin Invest 1973; 52: 2690-6.
55. Lange LG, Sobel BE. Mitochondrial dysfunction induced by fatty acid ethyl esters, myocardial metabolites of ethanol. J Clin Invest 1983; 72: 724-31.
56. Preedy VR, Peters TJ. The acute and chronic effects of ethanol on cardiac muscle protein synthesis in the rat in vivo. Alcohol 1990; 7: 97-102.
57. Preedy VR, Patel VB, Why HJ, Corbett JM, Dunn MJ, Richardson PJ. Alcohol and the heart: biochemical alterations. Cardiovasc Res 1996; 31: 139-47.
58. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 1999; 79: 215-62.
59. Meehan J, Piano MR, Solaro RJ, Kennedy JM. Heavy long-term ethanol consumption induces an alpha- to beta-myosin heavy chain isoform transition in rat. Basic Res Cardiol 1999; 94: 481-8. (Pubitemid 30018959)
60. 2+ transient. Am J Physiol 1998; 275 (1 Pt 2): H122-H130.
61. Piano MR, Rosenblum C, Solaro RJ, Schwertz D. Calcium sensitivity and the effect of the calcium sensitizing drug pimobendan in the alcoholic isolated rat atrium. J Cardiovasc Pharmacol 1999; 33: 237-42.
62. Noren GR, Staley NA, Einzig S, Mikell FL, Asinger RW. Alcohol-induced congestive cardiomyopathy: an animal model. Cardiovasc Res 1983; 17: 81-7. (Pubitemid 13116822)
63. 2+ channel in chronic alcoholic subjects without cardiomyopathy. Alcohol Clin Exp Res 2007; 31: 1099-105. Studio sperimentale su una piccola popolazione dimostrante che la cronica assunzione di alcool causa una "up-regulation" a livello miocardico di canali recettoriali del calcio tipo L.
64. Kim SD, Beck J, Bieniarz T, Schumacher A, Piano MR. A rodent model of alcoholic heart muscle disease and its evaluation by echocardiography. Alcohol Clin Exp Res 2001; 25: 457-63.
65. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998; 135 (5 Pt 1): 825-32. (Pubitemid 28237306)
66. Ogawa T, Linz W, Stevenson M, et al. Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production. Circulation 1996; 93: 2059-67. (Pubitemid 26165571)
67. Vikstrom KL, Bohlmeyer T, Factor SM, Leinwand LA. Hypertrophy, pathology, and molecular markers of cardiac pathogenesis. Circ Res 1998; 82: 773-8. (Pubitemid 28185844)
68. Cheng CP, Cheng HJ, Cunningham C, et al. Angiotensin II type 1 receptor blockade prevents alcoholic cardiomyopathy. Circulation 2006; 114: 226-36. (Pubitemid 44313579)
69. Vendemiale G, Grattagliano I, Altomare E, et al. Mitochondrial oxidative damage and myocardial fibrosis in rats chronically intoxicated with moderate doses of ethanol. Toxicol Lett 2001; 123: 209-16. (Pubitemid 32971726)
70. Kannan M, Wang L, Kang YJ. Myocardial oxidative stress and toxicity induced by acute ethanol exposure in mice. Exp Biol Med (Maywood) 2004; 229: 553-9. (Pubitemid 38736325)
71. Fatjó F, Fernández-Solá J, Lluís M, et al. Myocardial antioxidant status in chronic alcoholism. Alcohol Clin Exp Res 2005; 29: 864-70. (Pubitemid 40686557)
72. Duan J, McFadden GE, Borgerding AJ, et al. Overexpression of alcohol dehydrogenase exacerbates ethanol-induced contractile defect in cardiac myocytes. Am J Physiol Heart Circ Physiol 2002; 282: H1216-H1222.
73. 2+ release from sarcoplasmic reticulum. Am J Physiol Heart Circ Physiol 2008; 294: H121-H133. Lo studio suggerisce che l'acetaldeide agisce attraverso l'attivazione del recettore tipo 2 rianodinico per alterare la funzione miocardica.
74. Jänkälä H, Eriksson PC, Eklund K, Sarviharju M, Härkönen M, Mäki T. Effect of chronic ethanol ingestion and gender on heart left ventricular p53 gene expression. Alcohol Clin Exp Res 2005; 29: 1368-73.
75. Teragaki M, Takeuchi K, Toda I, et al. Point mutations in mitochondrial DNA of patients with alcoholic cardiomyopathy. Heart Vessels 2000; 15: 172-5. (Pubitemid 32573965)
76. Fernández-Solá J, Nicolás JM, Oriola J, et al. Angiotensin-converting enzyme gene polymorphism is associated with vulnerability to alcoholic cardiomyopathy. Ann Intern Med 2002; 137 (5 Pt 1): 321-6. (Pubitemid 34977133)
77. Lang CH, Frost RA, Summer AD, Vary TC. Molecular mechanisms responsible for alcohol-induced myopathy in skeletal muscle and heart. Int J Biochem Cell Biol 2005; 37: 2180-95.
78. Olsen EG. The pathology of cardiomyopathies. A critical analysis. Am Heart J 1979; 98: 385-92.
79. Brigden W, Robinson J. Alcoholic heart disease. Br Med J 1964; 2: 1283-9.
80. Regan TJ. Cuore, alcolismo e malattie nutrizionali. In: Hurst JW, ed. Il Cuore. New York, NY: McGrawHill, 1986: 1565.
81. Ferrans VJ, Hibbs RG, Weilbaecher DG, Black WC, Walsh JJ, Burch GE. Alcoholic cardiomyopathy; a histochemical study. Am Heart J 1965; 69: 748-65.
82. Alexander CS. Idiopathic heart disease. I. Analysis of 100 cases, with special reference to chronic alcoholism. Am J Med 1966; 41: 213-28.
83. Sachs RN, Vuong P, Beaudet B, Fischbein L, Nitenberg A, Lanfranchi J. Identification of prognostic criteria of dilated cardiomyopathies associated with chronic alcoholism. 22 cases. Presse Med 1988; 17: 1251-4.
84. Haissaguerre M, Fleury B, Gueguen A, et al. Mortality of dilated myocardiopathies as a function of continuation of alcohol drinking. Multivariate analysis concerning 236 patients. Presse Med 1989; 18: 711-4.
85. Estruch R, Fernández-Solá J, Mont L et al. Reversibility of alcoholic cardiomyopathy with abstinence: presentation of 2 cases. Med Clin (Barc) 1989; 92: 69-71.
86. Molgaard H, Kristensen BO, Baandrup U. Importance of abstention from alcohol in alcoholic heart disease. Int J Cardiol 1990; 26: 373-5. (Pubitemid 20061364)
87. Kosinski RM. Alcoholic cardiomyopathy. N J Med 1989; 86: 773-5.
88. Spodick DH, Pigott VM, Chirife R. Preclinical cardiac malfunction in chronic alcoholism. Comparison with matched normal controls and with alcoholic cardiomyopathy. N Engl J Med 1972; 287: 677-80.
89. Arroyo LH, Regan TJ. Ethanol and the heart. In: Topol EJ, ed. Textbook of cardiovascular medicine. 1st edition. Philadelphia, PA: Lippincott-Raven, 1998: 219-29.
90. Demakis JG, Proskey A, Rahimtoola SH, et al. The natural course of alcoholic cardiomyopathy. Ann Intern Med 1974; 80: 293-7.
91. Gavazzi A, De Maria R, Parolini M, Porcu M. Alcohol abuse and cardiomyopathy in men. Am J Cardiol 2000; 85: 1114-8.
92. Kupari M, Koskinen P, Suokas A, Ventilä M. Left ventricular filling impairment in asymptomatic chronic alcoholics. Am J Cardiol 1990; 66: 1473-7.
93. Mathews EC Jr, Gardin JM, Henry WL, et al. Echocardiographic abnormalities in chronic alcoholics with and without overt congestive heart failure. Am J Cardiol 1981; 47: 570-8.
94. Lazarevic AM, Nakatani S, Neskovic AN, et al. Early changes in left ventricular function in chronic asymptomatic alcoholics: relation to the duration of heavy drinking. J Am Coll Cardiol 2000; 35: 1599-606.
95. Fernández-Solá J, Nicolás JM, Paré JC, et al. Diastolic function impairment in alcoholics. Alcohol Clin Exp Res 2000; 24: 1830-5.
96. Rajzer M, Mertyna P, Betkowska-Korpala B, Kawecka-Jaszcz K. The effect of chronic alcohol consumption on systolic and diastolic left ventricular function. Przegl Lek 2004; 61: 895-901.
97. Brutsaert DL, Sys SU, Gillebert TC. Diastolic failure: pathophysiology and therapeutic implications. J Am Coll Cardiol 1993; 22: 318-25.
98. Verdecchia P, Schillaci G, Borgioni C, et al. Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy. Am J Cardiol 1996; 78: 197-202.
99. Kino M, Nakayama Y, Hara M, et al. Factors discriminating survivors and nonsurvivors in alcoholic heart disease. Heart Vessels Suppl 1985; 1: 301-5. (Pubitemid 16137204)
100. La Vecchia LL, Bedogni F, Bozzola L, Bevilacqua P, Ometto R, Vincenzi M. Prediction of recovery after abstinence in alcoholic cardiomyopathy: role of hemodynamic and morphometric parameters. Clin Cardiol 1996; 19: 45-50.
101. Fauchier L, Babuty D, Poret P, et al. Comparison of long-term outcome of alcoholic and idiopathic dilated cardiomyopathy. Eur Heart J 2000; 21: 306-14. (Pubitemid 30148302)
102. Nicolás JM, Fernández-Solá J, Estruch R, et al. The effect of controlled drinking in alcoholic cardiomyopathy. Ann Intern Med 2002; 136: 192-200.
103. Agatston AS, Snow ME, Samet P. Regression of severe alcoholic cardiomyopathy after abstinence of 10 weeks. Alcohol Clin Exp Res 1986; 10: 386-7.
104. Guillo P, Mansourati J, Maheu B, et al. Long-term prognosis in patients with alcoholic cardiomyopathy and severe heart failure after total abstinence. Am J Cardiol 1997; 79: 1276-8. (Pubitemid 27255182)
105. Djoenaidi W, Notermans SL, Dunda G. Beriberi cardiomyopathy. Eur J Clin Nutr 1992; 46: 227-34.
106. Milani L, Bagolin E, Sanson A. Improvement of left ventricular function in chronic alcoholics following abstinence from ethanol. Cardiology 1989; 76: 299-304.
107. Albanesi Filho FM, Castier MB, Boghossian SH, da Silva TT. Significance of alcohol abstinence in alcoholic cardiomyopathy with moderate left ventricular dysfunction. Arq Bras Cardiol 1998; 71: 781-5.
108. Kupari M. Reversibility of alcoholic cardiomyopathy. Postgrad Med J 1984; 60: 151-4.